Competitive intelligence · 27 October 2026
Comparators, revenue evidence and advertising
What public evidence supports, and what it does not. Named comparators are not a claim of an exhaustive leader ranking.
Dr. Kegel: two different revenue models
AppRank shows an approximately US$300,000 monthly iOS revenue estimate collected on 7 September 2026. Collection date is not the financial reporting month; its methodology describes legacy iOS estimates as worldwide. AppRank app record · Methodology.
MRRBeam models US App Store monthly revenue at US$41,000-$108,000 using store data observed on 12 October 2026. MRRBeam app record · Methodology.
These are separate third-party estimates with different coverage and dates, not a combined confidence interval, verified subscription MRR, audited revenue or profit. Store fees, taxes and off-store sales are not reconciled here. Neither model establishes category leadership or marketing spend.
What remains unknown
Kegel Men revenue remains unverified here. The earlier AppGoblin estimate has been withdrawn from the competitor table because its estimation method could not be established. No unverified replacement is supplied.
No reliable public marketing-budget figure was located for the comparators covered in this review. Ad counts are not budget estimates. Acquisition cost, conversion, retention and return on ad spend remain unknown unless separately sourced.
Research reviewed 27 October 2026. Reported company results, store-revenue models and subscription MRR are different measures. This update does not revalidate every older figure elsewhere on the page. Existing country-download context is all-app market data, not this category's demand. Any $100 million scenario remains illustrative, not a forecast.